December 8, 2022
RFA-TR-22-030 - Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)
National Institute of Neurological Disorders and Stroke (NINDS)
National Center for Advancing Translational Sciences (NCATS)
The purpose of this Notice is to inform potential applicants of the National Institute of Neurological Disorders and Stroke's (NINDS) participation in RFA-TR-22-030 "Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trials Not Allowed)" effective for the March 15, 2023 due date and subsequent due dates. Changes to the Funding Opportunity Announcement (FOA) are shown below.
Currently Reads:
Part 1. Overview Information
Components of Participating Organizations
National Center for Advancing Translational Sciences (NCATS)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
Assistance Listing Number
93.350, 93.242
Section II. Award Information
The NIH intends to commit approximately $1,500,000 in FY23, contingent upon receiving scientifically meritorious applications. 8-10 awards are anticipated from this solicitation. Future year amounts will depend on annual appropriations.
Scientific/Research Contact(s)
Karlie Sharma, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-451-4965
Email: DruggableGenome@mail.nih.gov
Enrique Michelotti, PhD
National Institute of Mental Health (NIMH)
Telephone: 301-443-5415
Email: michelottiel@mail.nih.gov
Financial/Grants Management Contact(s)
Steve Elsberg
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-827-0961
Email: steve.elsberg@nih.gov
Heather Weiss
National Institute of Mental Health (NIMH)
Telephone: 301-443-4415
Email: weissh@mail.nih.gov
Modified to Read:
Part 1. Overview Information
Components of Participating Organizations
National Center for Advancing Translational Sciences (NCATS)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
Assistance Listing Number
93.350, 93.242, 93.853
Section II. Award Information
The NIH intends to commit approximately $1,500,000 in FY23, contingent upon receiving scientifically meritorious applications. 8-10 awards are anticipated from this solicitation. Future year amounts will depend on annual appropriations.
The NINDS intends to commit approximately $600,000.00 in FY24, contingent upon receiving scientifically meritorious applications. 4-6 awards are anticipated from this solicitation. Future year amounts will depend on annual appropriaions.
Scientific/Research Contact(s)
Karlie Sharma, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-451-4965
Email: DruggableGenome@mail.nih.gov
Enrique Michelotti, PhD
National Institute of Mental Health (NIMH)
Telephone: 301-443-5415
Email: michelottiel@mail.nih.gov
Severn B. Churn, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
301-503-2889
severn.churn@nih.gov
Financial/Grants Management Contact(s)
Steve Elsberg
National Center for Advancing Translational Sciences (NCATS)
Telephone: 301-827-0961
Email: steve.elsberg@nih.gov
Heather Weiss
National Institute of Mental Health (NIMH)
Telephone: 301-443-4415
Email: weissh@mail.nih.gov
Chief Grants Management Officer
National Institute of Neurological Disorders and Stroke (NINDS)
Email: ChiefGrantsManagementOfficer@ninds.nih.gov
All other aspects of this FOA remain unchanged.
Severn B. Churn, PhD
National Institute of Neurological Disorders and Stroke (NINDS)
301-503-2889
severn.churn@nih.gov
and Human Services (HHS)
